In Brief: Reprocessed single-use devices
This article was originally published in The Gray Sheet
Executive Summary
Reprocessed single-use devices: Firms that reprocess single-use devices for multiple use will not at present be required to submit 510(k)s for the products to FDA, according to Kim Trautman, quality systems expert in the Center for Devices and Radiological Health. Speaking at an Oct. 25 Health Industry Manufacturers Association meeting in Washington, D.C., Trautman says FDA will exercise "regulatory discretion" by not requiring submissions for reprocessed disposables. CDRH Director Bruce Burlington believes "the agency needs to do more information gathering" before a final policy can be determined. A CDRH working group was formed earlier this year to draft a policy on the issue ("The Gray Sheet" April 22, I&W-3)...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.